Listed by the USPTO as OLSON, ANDREA STEFFEL
Tech Center 3700 • Art Units: 1623 1637 1656 1673 1693 3762
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18674521 | ENZYMATIC SYNTHESIS OF HOMOGENEOUS CHONDROITIN SULFATE OLIGOSACCHARIDES | Non-Final OA | The University of North Carolina at Chapel Hill |
| 17584129 | METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES | Non-Final OA | The Regents of the University of California |
| 18017306 | METHOD FOR MODULATING THE BLADDER MICROBIOME TO IMPROVE BLADDER HEALTH | Non-Final OA | Kimberly-Clark Worldwide, Inc. |
| 18277474 | MODIFIED ADENINES | Non-Final OA | NUCLERA LTD |
| 18720411 | METHOD AND COMPOSITION FOR TREATING PARASITES IN AN ANIMAL | Non-Final OA | Quality Technology International, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy62.4% of resolved applications examined by Andrea Steffel Olson were allowed (1,429 resolved cases), compared with 51.3% across Art Unit 1623 over the last five years.
This examiner's interview lift is -11.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Andrea Steffel Olson took 1,153 days on average from filing to allowance.
Andrea Steffel Olson examines applications in Art Unit 1623 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
